These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 13444690)

  • 21. [Current medicinal prevention & treatment of lead poisoning].
    BOCCIA D
    Sem Med; 1957 Nov; 111(20):985-8 passim. PubMed ID: 13519170
    [No Abstract]   [Full Text] [Related]  

  • 22. [First reports of treatment of bronzed diabetes with chelating agents].
    LANGERON L; PAGET M; ROUTIER G
    Bull Mem Soc Med Hop Paris; 1956; 72(27-28):911-5. PubMed ID: 13396597
    [No Abstract]   [Full Text] [Related]  

  • 23. [Trial treatment of silicosis by edathamil calcium; preliminary note].
    THIEBLOT L; CHAMPEIX J; LAVARENNE J; TEULADE R
    Arch Mal Prof; 1959; 20(2):151-5. PubMed ID: 13638046
    [No Abstract]   [Full Text] [Related]  

  • 24. [Treatment of hemochromatosis by chelating agents; report of three cases].
    LANGERON L; PAGET M; CROCCEL L; ROUTIER C
    Ann Biol Clin (Paris); 1958; 16(7-9):524-32. PubMed ID: 13595274
    [No Abstract]   [Full Text] [Related]  

  • 25. [Hemochromatosis in a castrate; treatment by a calcic chelating agent].
    VALLAT JN; TEXIER J; LAURES JC; DELUCHAT J; FAUCHER G
    Presse Med (1893); 1957 Dec; 65(95):2223 passim. PubMed ID: 13505720
    [No Abstract]   [Full Text] [Related]  

  • 26. Treatment of lead poisoning with calcium disodium versenate; a case report.
    CAPUTI S
    R I Med J; 1958 Jun; 41(6):321-2. PubMed ID: 13568475
    [No Abstract]   [Full Text] [Related]  

  • 27. [EDTA treatment in patients with atherosclerotic diseases].
    Alvik A; Wright PB
    Tidsskr Nor Laegeforen; 1993 Sep; 113(21):2717-8. PubMed ID: 8266299
    [No Abstract]   [Full Text] [Related]  

  • 28. [Treatment of 6 cases of pigmentary cirrhosis by blood letting & chelating agents].
    VACHON A; LEHMANN M; DHERS A
    Lyon Med; 1958 Mar; 90(12):457-66. PubMed ID: 13540355
    [No Abstract]   [Full Text] [Related]  

  • 29. [Clinical use of ethylenediaminetetracetic acid, sodium salt (titriplex III) as an anticoagulant].
    DETTORI AG
    G Clin Med; 1958 Sep; 39(9):1360-76. PubMed ID: 13610005
    [No Abstract]   [Full Text] [Related]  

  • 30. [Medical use of ethylenediamine tetraacetic acid (EDTA)].
    VARTIAINEN A
    Suom Laakaril; 1957 Aug; 12(16):802-7. PubMed ID: 13467593
    [No Abstract]   [Full Text] [Related]  

  • 31. [Indirect photometric determination of ethylenediaminetetraacetic acid].
    Suk V; Smetanová M
    Cesk Farm; 1965 May; 14(4):158-61. PubMed ID: 4953774
    [No Abstract]   [Full Text] [Related]  

  • 32. [Interaction between ethylenediaminetetraacetic acid and alkaline earth metals].
    TADDEI I
    Atti Accad Fisiocrit Siena Med Fis; 1957; 4():li-lv. PubMed ID: 13535404
    [No Abstract]   [Full Text] [Related]  

  • 33. [Ethylenediaminetetraacetic acid in pharmacy & medicine; its use in complexometry, therapy & technology].
    WENDT F
    Arch Pharm Ber Dtsch Pharm Ges; 1958 Mar; 291/63(3):33-43. PubMed ID: 13534565
    [No Abstract]   [Full Text] [Related]  

  • 34. [Analysis of ethylenediaminetetraacetic acid preparations].
    ABDINE H
    Arzneimittelforschung; 1956 Dec; 6(12):698-700. PubMed ID: 13395924
    [No Abstract]   [Full Text] [Related]  

  • 35. [Chelating agents during hypersiderinemia].
    LAMACHE A; BOUREL M; CORMIER ; LENOIR P; AZARD C; DELAHAYE D
    Bull Acad Natl Med; 1957 Feb 19-26; 141(7-8):137-43. PubMed ID: 13413354
    [No Abstract]   [Full Text] [Related]  

  • 36. [Indications for the therapeutic use of chelators in dermatology].
    THIERS H; COLOMB D; FAYOLLE J
    Bull Soc Fr Dermatol Syphiligr; 1957; 64(2):186-7. PubMed ID: 13460650
    [No Abstract]   [Full Text] [Related]  

  • 37. [EDTA again].
    Christensen EH
    Ugeskr Laeger; 2004 Nov; 166(48):4394-5; author reply 4395. PubMed ID: 15587642
    [No Abstract]   [Full Text] [Related]  

  • 38. [Calcium versenate in lead poisoning].
    MEYERS J; VAN DOMMELEN CK
    Ned Tijdschr Geneeskd; 1957 Jul; 101(27):1252-4. PubMed ID: 13451798
    [No Abstract]   [Full Text] [Related]  

  • 39. Chelating substances in medicine.
    ABINGTON RB
    U S Armed Forces Med J; 1958 Jul; 9(7):987-91. PubMed ID: 13569701
    [No Abstract]   [Full Text] [Related]  

  • 40. [Therapeutically usable nontoxic dose of calcium disodium ethylenediamine tetraacetate].
    GERGER T; MOESCHLIN S
    Praxis; 1959 Jun; 48(23):545-8. PubMed ID: 13667772
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.